Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Neogenomics Inc. (NASDAQ: NEO) was $15.51 for the day, up 1.37% from the previous closing price of $15.30. In other words, the price has increased by $1.37 from its previous closing price. On the day, 0.56 million shares were traded. NEO stock price reached its highest trading level at $15.7459 during the session, while it also had its lowest trading level at $15.33.
Ratios:
Our analysis of NEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.22 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.65.
On December 29, 2023, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $25 to $21.
Stephens Upgraded its Equal-Weight to Overweight on August 21, 2023, while the target price for the stock was maintained at $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when TETRAULT LYNN A. sold 6,112 shares for $15.97 per share. The transaction valued at 97,579 led to the insider holds 50,062 shares of the business.
Olivo Alicia C sold 2,587 shares of NEO for $38,713 on Feb 15 ’24. The General Counsel now owns 34,866 shares after completing the transaction at $14.96 per share. On Nov 17 ’23, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 2,669 shares for $18.39 each. As a result, the insider received 49,083 and left with 37,140 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1980813184 and an Enterprise Value of 2204165120. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.24 while its Price-to-Book (P/B) ratio in mrq is 2.14. Its current Enterprise Value per Revenue stands at 3.609 whereas that against EBITDA is -107.473.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $11.03. The 50-Day Moving Average of the stock is 3.78%, while the 200-Day Moving Average is calculated to be 1.08%.
Shares Statistics:
NEO traded an average of 948.07K shares per day over the past three months and 1178990 shares per day over the past ten days. A total of 127.37M shares are outstanding, with a floating share count of 126.25M. Insiders hold about 1.15% of the company’s shares, while institutions hold 99.37% stake in the company. Shares short for NEO as of 1713139200 were 7639948 with a Short Ratio of 8.06, compared to 1710460800 on 7289197. Therefore, it implies a Short% of Shares Outstanding of 7639948 and a Short% of Float of 8.34.
